RUNX3 and non-small cell lung carcinoma: Consistent with previous research on NSCLC, the overexpression of hsa-miR-301a-3p can reduce the cytotoxicity of NK cells and decrease the secretion of IFN-γ and TNF by targeting Runt-related transcription factor 3 (RUNX3).